Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix versus goserelin + bicalutamide for relief of lower urinary tract symptoms in locally advanced prostate cancer
2008-004338-26Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in prostate cancer (PCa) comparing Degarelix with Goserelin + bicalutamide (2 arms). Started Sep 2008; status: completed.
02
Drugs
degarelixgoserelinbicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-004338-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004338-26.